315 related articles for article (PubMed ID: 17448526)
21. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
22. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
[TBL] [Abstract][Full Text] [Related]
23. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
24. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
[TBL] [Abstract][Full Text] [Related]
25. An acetylation site in lectin domain modulates the biological activity of polypeptide GalNAc-transferase-2.
Zlocowski N; Lorenz V; Bennett EP; Clausen H; Nores GA; Irazoqui FJ
Biol Chem; 2013 Jan; 394(1):69-77. PubMed ID: 23096348
[TBL] [Abstract][Full Text] [Related]
26. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.
Gerken TA; Raman J; Fritz TA; Jamison O
J Biol Chem; 2006 Oct; 281(43):32403-16. PubMed ID: 16912039
[TBL] [Abstract][Full Text] [Related]
27. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning, expression, and characterization of UDP N-acetyl-α-d-galactosamine: Polypeptide N-acetylgalactosaminyltransferase 4 from Cryptosporidium parvum.
DeCicco RePass MA; Bhat N; Heimburg-Molinaro J; Bunnell S; Cummings RD; Ward HD
Mol Biochem Parasitol; 2018 Apr; 221():56-65. PubMed ID: 29581010
[TBL] [Abstract][Full Text] [Related]
29. Systematic identification of the protein substrates of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T1/T2/T3 using a human proteome microarray.
Xu Z; Li X; Zhou S; Xie W; Wang J; Cheng L; Wang S; Guo S; Xu Z; Cao X; Zhang M; Yu B; Narimatsu H; Tao SC; Zhang Y
Proteomics; 2017 Jun; 17(11):. PubMed ID: 28394504
[TBL] [Abstract][Full Text] [Related]
30. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
[TBL] [Abstract][Full Text] [Related]
31. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
[TBL] [Abstract][Full Text] [Related]
32. Identification of a family of four UDP-polypeptide N-acetylgalactosaminyl transferases in Cryptosporidium species.
Bhat N; Wojczyk BS; DeCicco M; Castrodad C; Spitalnik SL; Ward HD
Mol Biochem Parasitol; 2013 Sep; 191(1):24-7. PubMed ID: 23954365
[TBL] [Abstract][Full Text] [Related]
33. Expression in human ocular surface tissues of the GalNAc-transferases that initiate mucin-type O-glycosylation.
Imbert Y; Jumblatt MM; Foulks GN; Couzin EG; Steele PS; Young WW
Cornea; 2006 Dec; 25(10):1193-9. PubMed ID: 17172897
[TBL] [Abstract][Full Text] [Related]
34. Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses.
von Mensdorff-Pouilly S; Kinarsky L; Engelmann K; Baldus SE; Verheijen RH; Hollingsworth MA; Pisarev V; Sherman S; Hanisch FG
Glycobiology; 2005 Aug; 15(8):735-46. PubMed ID: 15814824
[TBL] [Abstract][Full Text] [Related]
35. Making Home Sweet and Sturdy: Toxoplasma gondii ppGalNAc-Ts Glycosylate in Hierarchical Order and Confer Cyst Wall Rigidity.
Tomita T; Sugi T; Yakubu R; Tu V; Ma Y; Weiss LM
mBio; 2017 Jan; 8(1):. PubMed ID: 28074022
[TBL] [Abstract][Full Text] [Related]
36. A simple bacterial expression system for human ppGalNAc-T and used for the synthesis of O-GalNAc glycosylated interleukin 2.
Liang T; Xu Z; Jia W; Zhang H; Yang F; Zou X; Zhang Y
Biochem Biophys Res Commun; 2020 Aug; 529(1):57-63. PubMed ID: 32560819
[TBL] [Abstract][Full Text] [Related]
37. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family.
Mandel U; Hassan H; Therkildsen MH; Rygaard J; Jakobsen MH; Juhl BR; Dabelsteen E; Clausen H
Glycobiology; 1999 Jan; 9(1):43-52. PubMed ID: 9884405
[TBL] [Abstract][Full Text] [Related]
38. ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential.
Wu Q; Zhang C; Zhang K; Chen Q; Wu S; Huang H; Huang T; Zhang N; Wang X; Li W; Liu Y; Zhang J
J Biol Chem; 2021; 296():100119. PubMed ID: 33234595
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.
Song L; Linstedt AD
Elife; 2017 Mar; 6():. PubMed ID: 28362263
[TBL] [Abstract][Full Text] [Related]
40. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
